Saitama, Japan

Shinichiro Kobayashi


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shinichiro Kobayashi

Introduction

Shinichiro Kobayashi is a notable inventor based in Saitama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that have therapeutic applications. His work focuses on enhancing immune response and providing solutions for various medical conditions.

Latest Patents

Kobayashi holds a patent for "2-Phenylimidazo[2,1-b]benzothiazole compounds, salts thereof, process of producing the compounds, and pharmaceutical compositions containing the compounds." This invention is particularly important as it addresses immune response issues, specifically in suppressing delayed type hypersensitivity reactions. The compounds developed by Kobayashi are useful as antiallergic agents, antirheumatics, therapeutic agents for autoimmune diseases, and suppressants of rejection in tissue transplantation and skin grafts. He has 1 patent to his name.

Career Highlights

Kobayashi has been associated with Yamanouchi Pharmaceutical Company Ltd., where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding of immune response and developing new therapeutic agents.

Collaborations

Throughout his career, Kobayashi has collaborated with notable colleagues such as Kiyoshi Murase and Toshiyasu Mase. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

Shinichiro Kobayashi's innovative work in the pharmaceutical field has led to significant advancements in immune response therapies. His contributions continue to impact the medical community positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…